U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Gene expression profiling of mammary epithelial cells from mice transiently exposed to tamoxifen

(Submitter supplied) The tumor suppressor gene p53 is frequently mutated in human breast cancer and is a marker for poor prognosis and resistance to chemotherapy. Transplantation of p53-null mouse mammary epithelium into syngeneic wild-type mice leads to normal mammary gland development followed by spontaneous mammary tumors that recapitulate many of the phenotypic, molecular, and genetic features of human breast cancer. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6096
6 Samples
Download data: CEL
Series
Accession:
GSE77948
ID:
200077948
2.

Puberty-specific promotion of mammary tumorigenesis by a high animal fat diet in P53 -/- mice

(Submitter supplied) Gene expression for genes differentially expressed between early vs. late tumor onset and high fat diet (HFD) vs. low fat diet (LFD) in P53 -/- mice.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL11202
41 Samples
Download data: TXT
Series
Accession:
GSE74294
ID:
200074294
3.

Expression data from Estrogen Receptor alpha-positive Progesterone Receptor-positive Mammary Tumors in STAT1-/- Mice.

(Submitter supplied) Aged STAT1-/- female mice spontaneously develop ERa+ PR+ mammary tumors that exhibit strikingly similar hormone-sensitivity and -dependency as human ERa+ luminal breast cancers. We used microarray data to compare the genetic relationships between the STAT1-/- mammary tumors and human breast cancers.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL1261
5 Samples
Download data: CEL
Series
Accession:
GSE31942
ID:
200031942
4.

Distinct luminal type mammary carcinomas arise from orthotopic Trp53 null mammary transplantation of juvenile versus adult mice

(Submitter supplied) Age and physiological status like menopause are key factors in mammary development and are associated with breast cancer risk. Less clear is what factors influence breast cancer intrinsic subtypes that are associated with prognosis. Here, we investigated the age of the host in a mammary chimera model. The mammary glands of wildtype BALB/c mice were cleared of endogenous epithelium at 3 weeks of age and subsequently transplanted during puberty (5 weeks) or upon maturation (10 weeks) with syngeneic Trp53null mammary fragments. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6887
27 Samples
Download data: TXT
Series
Accession:
GSE56726
ID:
200056726
5.

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer

(Submitter supplied) Tamoxifen is the most widely prescribed anti-estrogen treatment for patients with ER-positive breast cancer. However, there is still a need for biomarkers that reliably predict endocrine sensitivity in breast cancers and these may well be expressed in a dynamic manner. In this study we assessed gene expression changes at multiple time points (days 1, 2, 4, 7, 14) after tamoxifen treatment in the ER-positive ZR-75-1 xenograft model that displays significant changes in apoptosis, proliferation and angiogenesis within 2 days of therapy. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL506
32 Samples
Download data: TXT
Series
Accession:
GSE22386
ID:
200022386
6.

Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer

(Submitter supplied) WAP-Cre:Ptenf/f:p53lox.stop.lox_R270H composite mice were generated by genetic crossing. In these mice, Pten is deleted and a R270H p53 mutation in the DNA binding domain is induced upon expression of Cre recombinase in pregnancy-identified alveolar progenitors. Tumors were characterized by histology, marker analysis, various bioinformatics methods, high-throughput (HTP) FDA-drug screen as well as orthotopic injection to quantify tumor initiating cells (TICs) and tail-vein injection to identify lung-metastasis. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6246
31 Samples
Download data: CEL
Series
Accession:
GSE75989
ID:
200075989
7.

Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase over-expressing mice defines an immune-associated gene signature linked to tamoxifen resistance

(Submitter supplied) To investigate response or resistance to endocrine therapy, mice with targeted over-expression of Esr1 or CYP19A1 to mammary epithelial cells were employed, representing two direct pathophysiological interventions in estrogen pathway signaling. Both Esr1 and CYP19A1 over-expressing mice responded to letrozole with reduced HAN prevalence and decreased mammary epithelial cell proliferation. CYP19A1 over-expressing mice were tamoxifen-sensitive but Esr1 over-expressing mice were tamoxifen-resistant. more...
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL13112
17 Samples
Download data: TXT
Series
Accession:
GSE63857
ID:
200063857
8.

Microarray expression profiling of Runx1-null and wildtype mouse mammary epithelial cells

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL1261
21 Samples
Download data: CEL
Series
Accession:
GSE47377
ID:
200047377
9.

Microarray expression profiling of distinct subsets of mouse mammary epithelial cells

(Submitter supplied) The purpose of this microarray experiment was to obtain reference gene expression patterns of a number of epithelial cell populations [mammary stem cells (MASC), luminal progenitors (LP), alveolar luminal stem/progenitor cells (WC virgin-these are mammary epithelial cells genetically marked by Wap-Cre in virgin females), mature luminal cells (ML, mainly represent ductal luminal cells in virgin females), and alveolar luminal cells (WC preg – these are alveolar cells genetically marked by Wap-Cre during mid-gestation)] present in the mammary gland of wildtype adult mice on a C57BL6 genetic background.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL1261
15 Samples
Download data: CEL
Series
Accession:
GSE47376
ID:
200047376
10.

Microarray expression profiling study of Runx1-null and wild type luminal mammary epithelial cells

(Submitter supplied) RUNX1 encodes a RUNX family transcription factor (TF) and was recently identified as a novel mutated gene in human luminal breast cancers. We found that Runx1 is expressed in all subpopulations of murine mammary epithelial cells (MECs) except the secretory alveolar luminal cells. Conditional knockout of Runx1 in MECs by MMTV-Cre led to a decrease in luminal MECs, largely due to a profound reduction in the estrogen receptor (ER)-positive mature luminal subpopulation, a phenotype that could be rescued by loss of either Trp53 or Rb1. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL1261
6 Samples
Download data: CEL
Series
Accession:
GSE47375
ID:
200047375
11.

Non-targeted effects of low dose ionizing radiation act via TGFβ to promote mammary carcinogenesis

(Submitter supplied) It is widely believed that the carcinogenic action of ionizing radiation is due to targeted DNA damage and resulting mutations, but there is also substantial evidence that non-targeted radiation effects alter epithelial phenotype and the stromal microenvironment. Activation of transforming growth factor β1 (TGFβ) is a non-targeted radiation effect that mediates cell fate decisions following DNA damage and regulates microenvironment composition; it could either suppress or promote cancer. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL1261
65 Samples
Download data: CEL
Series
Accession:
GSE18216
ID:
200018216
12.

Rb deletion in mammary stem/progenitor epithelium induces tumors with features of luminal-B or basal-like breast cancer

(Submitter supplied) The retinoblastoma tumor suppressor, Rb, is implicated in luminal-B and basal-like breast carcinomas, yet its effect on mammary gland development and causal role in breast cancer subtypes remain undefined. Here we show that conditional deletion of Rb in mouse mammary epithelium led to expansion of the stem/progenitor cells and to focal acinar hyperplasia with squamous metaplasia. These uniform lesions progressed into histologically diverse, transplantable mammary adenocarcinomas and adenosquamous carcinomas with features of luminal-B or basal-like carcinomas. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platforms:
GPL891 GPL4092 GPL2881
144 Samples
Download data
Series
Accession:
GSE14457
ID:
200014457
13.

Transcriptional Profiling of Responses to Estrogen and Progesterone in Mammary Gland

(Submitter supplied) Epidemiological studies have shown that a full-term pregnancy at early age can decrease the breast cancer risk up to one-half. Pregnancy has been shown to prevent carcinogen-induced mammary tumors in rodents as well. The protective effect of pregnancy can be mimicked by administration of estrogen and progesterone to nulliparous rodents in amounts that are similar to those during pregnancy and alters responsiveness of p53 to DNA damage. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platforms:
GPL82 GPL83 GPL81
60 Samples
Download data
Series
Accession:
GSE5483
ID:
200005483
14.

Stromal PTEN determines mammary epithelial response to radio-therapy

(Submitter supplied) It is well-described that the tumor stroma participates in cancer progression, but whether stromal factors can initiate breast tumorigenesis remains unclear. Using our previously described stromal-specific phosphatase and tensin homolog (PTEN) deletion mouse model, we investigated transformative events in young, non-tumor bearing animals. Here, we show stromal PTEN deletion initiates radiation-induced genomic instability on neighboring mammary epithelium through paracrine epidermal growth factor receptor (EGFR) activation. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL20775
6 Samples
Download data: CEL
Series
Accession:
GSE93784
ID:
200093784
15.

Paternal malnutrition programs offspring’s breast cancer risk and tumor metabolism in a mouse model

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Mus musculus
Type:
Non-coding RNA profiling by high throughput sequencing; Methylation profiling by high throughput sequencing
Platforms:
GPL21103 GPL9250
27 Samples
Download data
Series
Accession:
GSE114423
ID:
200114423
16.

Paternal malnutrition programs offspring’s breast cancer risk and tumor metabolism in a mouse model (MBD-seq)

(Submitter supplied) We found that LP daughters have lower birthweight, alterations in mammary gland morphology and higher rates of mammary cancer. Further, we found that mammary glands and tumors of LP daughters are metabolic rewired, with alterations in the AMPK and amino-acid metabolism pathways. These changes were associated with differential expression of miRNAs 451a, miR-200c and miR-92a. Importantly, some of the same miRNAs and target genes alterations were detected in breast tumors of women from populations with high rates of low birthweight.
Organism:
Mus musculus
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL9250
11 Samples
Download data: TXT
Series
Accession:
GSE114422
ID:
200114422
17.

Paternal malnutrition programs offspring’s breast cancer risk and tumor metabolism in a mouse model (small RNA-seq)

(Submitter supplied) We found that LP daughters have lower birthweight, alterations in mammary gland morphology and higher rates of mammary cancer. Further, we found that mammary glands and tumors of LP daughters are metabolic rewired, with alterations in the AMPK and amino-acid metabolism pathways. These changes were associated with differential expression of miRNAs 451a, miR-200c and miR-92a. Importantly, some of the same miRNAs and target genes alterations were detected in breast tumors of women from populations with high rates of low birthweight.
Organism:
Mus musculus
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL21103
16 Samples
Download data: TXT
Series
Accession:
GSE114421
ID:
200114421
18.

Mammary Gland Morphological and Gene Expression Changes Underlying Pregnancy Protection of Breast Cancer Tumorigenesis

(Submitter supplied) Pregnancy has been shown to decrease the risk of mammary carcinogenesis in human rretrospective epidemiological studies. In rodents, pregnancy prior to carcinogen administration or after carcinogen challenge has also been shown to reduce the incidence of palpable carcinomas. In this study our objective to determine the underlying genomic signature of the pregnancy and reproductive hormones on the mammary gland that contribute to the protection against mammary gland carcinogenesis. more...
Organism:
Rattus norvegicus
Type:
Expression profiling by array
Dataset:
GDS4081
Platform:
GPL1355
15 Samples
Download data: CEL, TXT
Series
Accession:
GSE32125
ID:
200032125
19.
Full record GDS4081

Effect of full-term pregnancy or hormone treatment on inguinal left mammary gland

Analysis of mammary gland of metestrus Lewis females randomly assigned to 3 groups: control, pregnancy, or hormone (exogenous estrogen and progesterone). Full-term pregnancy or treatment with hormone reduces breast cancer risk. Results provide insight into molecular basis of the protective effect.
Organism:
Rattus norvegicus
Type:
Expression profiling by array, transformed count, 2 agent, 2 development stage, 3 protocol sets
Platform:
GPL1355
Series:
GSE32125
15 Samples
Download data: CEL
20.

Global gene expression profiling reveal distinct molecular profiles between p53-sensitive and p53-resistant T-cell lymphomas

(Submitter supplied) TP53 mutations occur in approximately 50% of all human tumors with increased frequency in aggressive cancers that are notoriously difficult to treat. Additionally, p53 missense mutations are remarkably predictive of refractoriness to chemo/radiotherapy in various malignancies. These observations have led to the development of mutant-p53 targeting agents that restore p53 function. An important unknown is which p53-mutant tumors will respond to p53 reactivation-based therapies. more...
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL21493
12 Samples
Download data: TXT
Series
Accession:
GSE109883
ID:
200109883
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=4|qty=4|blobid=MCID_6688e53349fc8a23253cfdcf|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Support Center